NDC 58198-0507 - Component E-C With Tylan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58198-0507
- Package NDCs from labels
- 58198-0507-2
- Manufacturer
- Elanco US Inc.
- Effective date
- 2025-11-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Component E-C With Tylan - Elanco US Inc. | Elanco US Inc. | 2025-11-21 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58198-0507-2 | Component E-C With Tylan | 1 in 1 POUCH | IMPLANT | 1 | 11 | |
| 58198-0507-2 | Component E-C With Tylan | 5 in 1 CARTON | IMPLANT | 5 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 58198-0507 | COMPONENT E-C WITH TYLAN (PROGESTERONE, ESTRADIOL BENZOATE, TYLOSIN TARTRATE) IMPLANT [ELANCO US INC.] | 10 | 2 package rows | 20250122_bfc05acf-01ff-4b77-ae5c-7d5da9c03aa9.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PROGESTERONE | PROGESTERONE | Bionpharma Inc. | 3acad9b0-7ec6-4d5e-9852-32ffadbbed6d | 2018-03-11 | Boxed warning, Warnings, Adverse reactions | 4G7DS2Q64Y |
| Estrogen and Progesterone | AGNUS CASTUS, ANGELICA SINENSIS, APIS MELLIFICA, ARNICA MONTANA, CIMICIFUGA RACEMOSA, ESTRADIOL, ESTRIOL, FOLLICULINUM, GALIUM APARINE, GLYCYRRHIZA GLABRA, KOREAN GINSENG, OOPHORINUM (SUIS), PROGESTERONE, SEPIA, THUJA OCCIDENTALIS, VISCUM ALBUM | ProBLEN | 71fec93b-43b7-4ebb-ab5c-5f544d8e6cbf | 2017-01-12 | Warnings | 4G7DS2Q64Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.